Dynamk Consulting

What Dynamk Consulting does

Dynamk Consulting LLC is a privately held, boutique business development advisory firm headquartered in the United States and operated by Founder & CEO Daniella Kranjac. The firm provides strategic advisory services to management teams and executive boards across the life sciences and biopharma value chain, with a stated service portfolio covering investment due diligence, technical and market assessments, investment fund strategy and thesis development, product and commercial development for new and disruptive technologies, marketing strategy and segmentation, go-to-market planning, commercial roll-out support, and C-suite solution sale expertise. Its stated client base spans early and growth-stage entrepreneurial ventures, investment firms, multinational biopharma, and Fortune 100 organizations in both developed and emerging markets.

The firm's underlying "technology" is professional judgment rather than a software product. Its core differentiator is concentrated in the founder, who holds undergraduate degrees in Chemical and Biochemical Engineering from Stevens Institute of Technology, an Executive MBA from NYU Stern School of Business, and executive education in Private Equity and Venture Capital from Harvard Business School. The founder's prior track record includes co-founding Wave Biotech LLC from a university dormitory and partner's garage, commercializing it to a successful exit via acquisition by GE Healthcare Life Sciences, and previously launching, commercializing, and globalizing a several hundred million dollar enterprise solutions business. The firm has no disclosed patents, proprietary software, AI/ML capabilities, or productized technology platforms.

Dynamk operates a sales-led, relationship-based go-to-market model in which client acquisition is driven by the founder's personal network of C-suite executives, process development and manufacturing leaders, and engineering teams. Revenue is generated through professional services engagements with bespoke, quote-based pricing that is not publicly disclosed. Marketing is limited to a professional website (dynamk.consulting) and reputation-driven referrals. The company has no disclosed funding, no institutional investors, no parent company, no subsidiaries, and no publicly reported revenue or headcount figures; only the founder is listed in management.

Name

Dynamk Consulting

Legal name

DYNAMK Consulting, LLC

Website

https://dynamk.consulting

Company type

Private

Founded year

2015

Operating status

Operating

Headcount range

1–10 employees

Short description

Dynamk Consulting is a boutique advisory firm providing business development, commercialization, and investment due diligence services to life sciences, biopharma, investment firms, and early-stage ventures globally, delivered by founder and CEO Daniella Kranjac.

Ownership category

akta.pro rank

Product category

Management Consulting

NAICS

Management Consulting Services (54161), Marketing Consulting Services (541613)

SIC

Services-Management Consulting Services (8742)

akta.pro primary industry

Strategy & Corporate Development Consulting (BPAHACAA)

akta.pro secondary industries

Customer, Marketing & Sales Consulting (BPAHACAG), Innovation, Product & R&D Consulting (BPAHACAM)

Keywords

• Life sciences consulting
• Business development advisory
• Biopharma strategy consulting
• Go-to-market consulting
• Commercial strategy advisory

Headquarters

HQ city

New York

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Marketing or Sales, Operations, Others

Revenue model

1. Consulting and Advisory Services: Professional services engagement providing strategic advisory to management and executive boards in life sciences, biopharma, and emerging markets. Engagements include investment due diligence, technical and market assessments, fund strategy development, product and commercial development, marketing strategy, and go-to-market planning.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Core offering

Dynamk Consulting is a boutique advisory firm that provides business development consulting services to life sciences, biopharma, and investment organizations. Engagements span investment due diligence and technical/market assessments, investment fund strategy and thesis development, product and commercial development for new and disruptive technologies, marketing strategy and segmentation, go-to-market planning with commercial roll-out support, C-suite solution sales expertise, and internal infrastructure creation with cross-functional team alignment. Clients include early and growth-stage entrepreneurial ventures as well as Fortune 100 organizations and investment firms in developed and emerging markets.

Product overview

Dynamk Consulting is a business development consulting firm that offers advisory services to life sciences, biopharma, and related organizations. Rather than a software product platform, the company provides a suite of consulting services including investment due diligence, technical and market assessments, investment fund strategy development, product and commercial development, marketing strategy creation and implementation, go-to-market planning, commercial roll-out support, and C-suite solution sales expertise. The firm serves both early-stage entrepreneurial ventures and large organizations, functioning as trusted advisors to management and executive boards.

Differentiator

Problem solved

Functional benefit

Products and services

• Business Development and Commercial Strategy Advisory Services Boutique advisory suite covering investment due diligence, technical and market assessments, investment fund strategy and thesis development, product and commercial development for new and disruptive technologies, marketing strategy and segmentation, go-to-market planning, commercial roll-out support, C-suite solution sales expertise, and internal infrastructure creation with cross-functional team alignment. Delivered to management and executive boards of early and growth-stage life sciences ventures, Fortune 100 organizations, and investment firms.

Quantifiable outcome

• Successfully launched, commercialized and globalized a several hundred million dollar enterprise solutions business
• +1 more outcomes

Named customers1 record

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators3 records

Recent moves4 records

Expansion highlights4 records

Direct peers

• ZS Associates: Global consulting firm focused on life sciences and pharma commercial strategy, sales, and marketing. Highly comparable to Dynamk because both serve biopharma clients on go-to-market, commercialization and customer engagement, though ZS operates at far greater scale.
• Trinity Life Sciences: Life sciences-focused advisory firm providing commercial strategy, market assessment, and evidence solutions to biopharma. Closely comparable to Dynamk in vertical focus (life sciences) and service mix (commercial strategy, market assessment, evidence-driven consulting).
• L.E.K. Consulting: Global strategy consulting firm with a deep life sciences and biopharma practice covering commercial strategy, M&A and product launches. Directly comparable to Dynamk on the strategy and commercial advisory work for life sciences clients.
• ClearView Healthcare Partners: Boutique strategy consulting firm dedicated to life sciences, serving biotech and biopharma on commercial strategy, pipeline positioning, and launch planning. Closely comparable to Dynamk's boutique, life-sciences-only commercial advisory model.
• Charles River Associates: Consulting firm with a strong life sciences practice providing commercial strategy, market access and economic advisory to biopharma clients. Comparable to Dynamk on life sciences advisory and on serving investment-firm due diligence mandates.
• Simon-Kucher & Partners: Global consulting firm specializing in commercial strategy, pricing, and go-to-market across life sciences and other industries. Comparable to Dynamk on the commercial strategy and GTM planning work for biopharma clients.

Broad incumbents

• Bain & Company: Global strategy consulting firm with a dedicated life sciences practice covering M&A, commercialization and operating model work. Broad incumbent that competes for the same enterprise biopharma advisory mandates as Dynamk at significantly greater scale.
• McKinsey & Company: Global management consulting leader with a large pharma and medical products practice covering strategy, commercialization, and M&A. Broad incumbent competing for the same enterprise and biopharma mandates as Dynamk.
• Boston Consulting Group: Global strategy consulting firm with deep biopharma and biotech practices covering corporate strategy, commercialization and innovation. Broad incumbent serving the same Fortune 100 and biopharma clients that Dynamk targets.

Emerging players

• DeciBio Consulting: Niche life sciences strategy consulting firm focused on precision medicine, diagnostics and biotech commercial strategy. Comparable to Dynamk on boutique scale and life sciences vertical focus, with deeper specialization in diagnostics-adjacent markets.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Dynamk Consulting